Qigong for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong is the most accessible for adults with SCI with evidence for effectiveness in reducing pain, but there is insufficient evidence to make recommendations for adults with SCI. Thus, the feasibility of Qigong in SCI needs to be established. To support our feasibility study, we investigated a 12-week remote Qigong program in adults with SCI and neuropathic pain. We recruited 23 adults with SCI, 18 completed the study, and 12 completed the 1-year follow-up. They practiced Qigong 138% of the required intensity (which was, at least 3x/week with Qigong video through the internet). Their pain was reduced by 44% after 12 weeks of Qigong practice and was still reduced at the 6-week and 1-year follow-up. However, three key elements need to be addressed before performing a larger effectiveness study: (1) feasibility/acceptability of Qigong from adults with SCI of diverse backgrounds; (2) feasibility of the study design with control group); and (3) objective outcome measures. This R34 feasibility study, the HAPPINESS trial (cHAnging the Perceived Pain INtensity in divErSe populations with Spinal cord injury), will expand on our prior study to consolidate feasibility with a rigorous protocol. We will address the following aims: AIM 1. Identify the facilitators/barriers to participating in a Qigong study through focus groups/interviews with stakeholders from diverse backgrounds, defined as Hispanics, veterans, and adults living in rural, underserved areas. AIM 2. Establish the feasibility of study design/methods of the HAPPINESS trial in adults with SCI (at least 50% of diverse backgrounds) through pre-specified targets for recruitment/enrollment, feasibility, and acceptability of design and outcomes. Using a Phase I randomized controlled trial design, 40 adults with SCI-related neuropathic pain will be randomized to 12-week remote Qigong intervention OR a short daily pain management survey that can be completed on phone/iPad/computer + 6-month follow-up. The study results will facilitate a rigorous structure to design larger effectiveness studies and facilitate a clear pathway for researchers to investigate Qigong and other mind-body approaches for whole-person health in diverse groups of adults with chronic/neurological disorders.
Do I need to stop my current medications for the Qigong trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue them, but please confirm with the study coordinators.
What data supports the effectiveness of the treatment Qigong for spinal cord injury?
Is Qigong generally safe for humans?
How does the Qigong treatment for spinal cord injury differ from other treatments?
Qigong is unique because it is a non-drug therapy that involves gentle movements and kinesthetic imagery to improve body awareness and reduce neuropathic pain, which is often resistant to other treatments. It can be practiced remotely, making it accessible and convenient for individuals with spinal cord injury.12111213
Research Team
Ann Van de Winckel, PhD, MS, PT
Principal Investigator
University of Minnesota
Eligibility Criteria
The HAPPINESS Trial is for adults over 18 with spinal cord injury and chronic neuropathic pain who can participate in remote Qigong sessions. Participants need internet access, a computer or smartphone, and must speak English or Spanish. They should be medically stable with measurable neuropathic pain.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to a 12-week remote Qigong intervention or a short daily pain management survey
Follow-up
Participants are monitored for adherence and outcomes post-intervention
Treatment Details
Interventions
- Qigong (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Shashank Priya
University of Minnesota
Chief Executive Officer since 2023
PhD in Materials Engineering from Penn State
Charles Semba
University of Minnesota
Chief Medical Officer since 2021
MD from the University of Minnesota Medical School